The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
289.10
-2.00 (-0.69%)
At close: May 13, 2025
DSE:IBNSINA Revenue
The IBN SINA Pharmaceutical Industry had revenue of 2.88B BDT in the quarter ending March 31, 2025, with 12.89% growth. This brings the company's revenue in the last twelve months to 11.80B, up 8.63% year-over-year. In the fiscal year ending June 30, 2024, The IBN SINA Pharmaceutical Industry had annual revenue of 11.37B with 24.61% growth.
Revenue (ttm)
11.80B
Revenue Growth
+8.63%
P/S Ratio
0.77
Revenue / Employee
2.81M
Employees
4,200
Market Cap
9.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 11.37B | 2.25B | 24.61% |
Jun 30, 2023 | 9.13B | 645.51M | 7.61% |
Jun 30, 2022 | 8.48B | 1.10B | 14.96% |
Jun 30, 2021 | 7.38B | 1.18B | 19.13% |
Jun 30, 2020 | 6.19B | 927.67M | 17.62% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grameenphone | 157.46B |
Square Pharmaceuticals PLC. | 75.86B |
British American Tobacco Bangladesh Company | 99.45B |
Robi Axiata PLC. | 99.50B |
Walton Hi-Tech Industries | 78.24B |
Bangladesh Export Import Company | 17.72B |
BRAC Bank PLC. | 60.66B |
Berger Paints Bangladesh | 27.70B |